The length of time between surveillance procedures varies and is largely up to the physician
I cared specifically about who actually names their 503A pharmacy partners, what your true monthly cost looks like after the intro promo wears off, and how flexible each provider is on dosing format
These concerns are why experts emphasize that GLP-1s are a tool, not the entire solution
Novo Nordisks Response to JAMA Study and Allegations In an emailed statement, Wegovy manufacturer Novo Nordisk countered that there were several limitations of the JAMA study design, which was not a randomized controlled trial, as reported by Reuters
10.1046/j.1365-2125.2003.01907.x 53 SterneJ.HernnM.ReevesB.SavoviJ.BerkmanN.ViswanathanM.et al (2016)
Reviewed by a Longevity Practitioner Laura Morgan Medical Reviewer (CLP, LPI Longevity Practitioner) Scientific Reviewer at Longevity Direct